Continuous epileptiform discharges in patients treated with cefepime or meropenem

Archives of Neurology

Volumn 68, Issue 10, 2011, Pages 1301-1305

  Naeije, Gilles ^a   Lorent, Sophie ^a   Vincent, Jean Louis ^a   Legros, Benjamin ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CEFEPIME; MEROPENEM; VALPROIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; THIENAMYCIN DERIVATIVE; ETIRACETAM; PHENYTOIN; TOPIRAMATE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BELGIUM; CREATININE BLOOD LEVEL; DATA BASE; DRUG FATALITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ELECTROLYTE DISTURBANCE; EPILEPTIC DISCHARGE; FISHER EXACT TEST; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; UNIVERSITY HOSPITAL; AGED; BACTERIAL INFECTION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CROSSOVER PROCEDURE; EPILEPSY; FEMALE; HOSPITAL PHARMACY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICS; CONTINUOUS GENERALIZED EPILEPTIFORM DISCHARGE; CONTROLLED STUDY; DATA ANALYSIS; FEBRILE NEUTROPENIA; GASTROINTESTINAL INFECTION; HYPERTRANSAMINASEMIA; LUNG INFECTION; SEPSIS; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BELGIUM; CEPHALOSPORINS; CROSS-OVER STUDIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; RETROSPECTIVE STUDIES; THIENAMYCINS;

EID: 80053896849     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.204     Document Type: Article

References (13)

1. Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7(5):338-348. (Pubitemid 46591956)
2. Fernández-Torre JL, Martínez-Martínez M, González-Rato J, et al. Cephalosporin induced nonconvulsive status epilepticus: clinical and electroencephalographic features. Epilepsia. 2005;46(9):1550-1552.
3. Dakdouki GK, Al-Awar GN. Cefepime-induced encephalopathy. Int J Infect Dis. 2004;8(1):59-61. (Pubitemid 38094905)
4. Martínez-Rodríguez JE, Barriga FJ, Santamaría J, et al. Nonconvulsive status epilecticus associated with cephalosporins in patients with renal failure. Am J Med. 2011;111:115-119.
5. Jirsch J, Hirsch LJ. Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin Neurophysiol. 2007;118(8):1660-1670. (Pubitemid 47031710)
6. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47(1):83-89. (Pubitemid 26243864)
7. Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med. 2009;37(6): 2051-2056.
8. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996; 46(4):1029-1035. (Pubitemid 26134646)
9. Hirsch LJ. Urgent continuous EEG (cEEG) monitoring leads to changes in treatment in half of cases. Epilepsy Curr. 2010;10(4):82-85.
10. Sugimoto M, Uchida I, Mashimo T, et al. Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003;45(3):304-314. (Pubitemid 36836127)
11. Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav. 2006;8(1): 312-314. (Pubitemid 43103866)
12. Flierl MA, Rittirsch D, Huber-Lang MS, Stahel PF. Pathophysiology of septic encephalopathy: an unsolved puzzle. Crit Care. 2010;14(3):165.
13. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743-1748. (Pubitemid 38661728)